Scleroderma Support Group Survey
Do you have scleroderma? Are you interested in helping advance research on scleroderma support groups? If so, please lend a hand by completing this short 10-15 minute survey!
Our team, which is comprised of international researchers; people with scleroderma; and leaders from the Federation of European Scleroderma Associations, the Scleroderma Foundation of the United States, and the Scleroderma Society of Canada are working
together to learn more about the experiences of scleroderma support group facilitators, scleroderma support group members, and people who choose not to attend scleroderma support groups.
Your anonymous answers to the survey questions will provide a greater understanding of the important training and support needs of group leaders, as well as the reasons why people with scleroderma either attend or do not attend support groups. The results from this survey will be used to increase the accessibility of scleroderma support groups and to structure these groups in a way that increases their ability to effectively meet the needs of members.
If you have a few minutes to spare and are able to help with this exciting research project, please click on the following link, which will take you directly to the survey:
If you have any additional questions or concerns about the survey, please contact any member of our research team listed below:
MS. STEPHANIE GUMUCHIAN
MSc. Psychiatry Student, McGill University
Telephone: (514) 340-8222 ext. 6813; Email: email@example.com
MS. VANESSA DELISLE
PhD. Counselling Psychology Student, McGill University
Telephone: (514) 340-8222 ext. 6812; Email: firstname.lastname@example.org
MS. MIA PEPIN
BSc. Psychology Student, Université de Montréal
Telephone: (514) 340-8222 ext. 8578; Email: email@example.com
news & events
The European Medicine Agency is urging the general public NOT to buy medicines from unauthorized websites.
We know these are worrying times. We have gathered information to answer your questions and concerns.
Join the webinar on Scleroderma and COVID-19 this Saturday, March 21.